Oxbryta Disease Interactions
There are 2 disease interactions with Oxbryta (voxelotor).
Voxelotor (applies to Oxbryta) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Dose reduction for voxelotor is recommended for patients with severe hepatic impairment. The daily recommended dose for these patients is 1,000 mg. No dosage adjustment is required for patients with mild or moderate hepatic impairment.
Voxelotor (applies to Oxbryta) hypersensitivity
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Allergies
Serious hypersensitivity reactions have occurred in patients treated with voxelotor. If hypersensitivity reactions occur, discontinue treatment and administer appropriate medical therapy. Do not reinitiate voxelotor in patients who experience hypersensitivity reactions with previous use.
Switch to professional interaction data
Oxbryta drug interactions
There are 366 drug interactions with Oxbryta (voxelotor).
Oxbryta alcohol/food interactions
There is 1 alcohol/food interaction with Oxbryta (voxelotor).
More about Oxbryta (voxelotor)
- Oxbryta consumer information
- Check interactions
- Compare alternatives
- Reviews (7)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.